StonvexLoading…
StonvexStonvexStonvexCore line items from CNK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $643.10M | $3.12B | $2.34B | $1.48B |
Operating Income | Not available | $153.90M | Not available | Not available |
Net Income | $-6.40M | $138.20M | $104.10M | $54.60M |
EPS (Diluted) | $-0.06 | $1.04 | $0.77 | $0.38 |
Total Assets | Not available | Not available | Not available | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $0.00 | Not available | Not available |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 114.70M | 134.30M | 139.40M | 155.00M |